High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

  1. Zapatero, A.
  2. Guerrero, A.
  3. Maldonado, X.
  4. Álvarez, A.
  5. San-Segundo, C.G.
  6. Rodríguez, M.Á.C.
  7. Solé, J.M.
  8. Olivé, A.P.
  9. Casas, F.
  10. Boladeras, A.
  11. de Vidales, C.M.
  12. de la Torre, M.L.V.
  13. Vara, S.
  14. Sanz, J.L.
  15. Calvo, F.A.
Aldizkaria:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Argitalpen urtea: 2022

Alea: 23

Zenbakia: 5

Orrialdeak: 671-681

Mota: Artikulua

DOI: 10.1016/S1470-2045(22)00190-5 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak